Clinical Excellence in Continuity of Care: Counterpart Assistant (CA) Use Associated With Stronger Performance Across Transitions of Care Measures and Post-Hospitalization Follow-Up

Rhea-AI Summary

Clover Health (Nasdaq:CLOV) subsidiary Counterpart Health released a whitepaper analyzing Counterpart Assistant (CA) use in high-risk care transitions for its Medicare Advantage population.

CA-enabled PCPs were associated with better HEDIS® Transitions of Care and FMC performance, including 33% higher discharge information receipt, 11% higher medication reconciliation, and 9% higher ED follow-up rates.

Positive

• CA-enabled PCPs showed better performance across all reviewed HEDIS Transitions of Care measures
• Members with CA-enabled PCPs had a 33% higher rate of discharge information receipt
• Members with CA-enabled PCPs had an 11% higher rate of post-discharge medication reconciliation
• Members with CA-enabled PCPs had a 9% higher rate on the HEDIS FMC follow-up measure
• Analysis builds on data underlying Clover’s #1 HEDIS score for a PPO Medicare Advantage plan over the last two years

Negative

• None.

News Market Reaction – CLOV

-1.19%

13 alerts

-1.19% Session close to close

-4.4% Trough in 3 hr 59 min

$2.67B Market Cap

0.8x Rel. Volume

In the Jul 7 session, CLOV declined 1.19%, reflecting a mild negative market reaction. Argus tracked a trough of -4.4% from its starting point during tracking. Our momentum scanner triggered 13 alerts that day, indicating notable trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The whitepaper links Counterpart Assistant to a 33% boost in discharge information receipt and an 11...

Analysis

The whitepaper links Counterpart Assistant to a 33% boost in discharge information receipt and an 11% improvement in medication reconciliation, extending Clover’s prior HEDIS results. Investors may weigh these quality gains against recent insider net selling and broader execution risks.

Key Figures

Discharge info rate: 33% higher Medication reconciliation rate: 11% higher FMC measure performance: 9% higher rate +2 more

5 metrics

Discharge info rate 33% higher Receipt of discharge information for CA-enabled PCP members

Medication reconciliation rate 11% higher Post-discharge medication reconciliation for CA-enabled PCP members

FMC measure performance 9% higher rate HEDIS FMC follow-up after ED visits for high-risk chronic conditions

CA impact studies 8 retrospective analyses Number of Counterpart Assistant clinical impact whitepapers completed

HEDIS ranking #1 HEDIS score Nationwide PPO Medicare Advantage plan ranking for last two years

Historical Context

4 past events · Latest: May 06 (Positive)

Pattern 4 events

Date	Event	Sentiment	24h Move	Catalyst
May 06	Q1 2026 earnings	Positive	+5.2%	Profitable Q1 results with detailed 2026 revenue and earnings guidance.
Apr 08	Earnings date notice	Neutral	-0.5%	Announcement of timing and webcast details for upcoming Q1 2026 report.
Apr 07	HealthEx partnership	Positive	+1.6%	New data-sharing partnership enabling members to access and share health data.
Mar 19	CA flu-outcomes data	Positive	+0.5%	Whitepaper linking Counterpart Assistant use to fewer flu-related acute events.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Clover’s shares have generally aligned with prior operational and data-driven updates, with one notable divergence on a partnership announcement.

Key Terms

hedis, transitions of care, follow-up after emergency department visit for people with multiple high-risk chronic conditions, medication reconciliation

4 terms

hedis medical

"including two HEDIS quality measures within Clover Health’s Medicare Advantage population"

HEDIS is a standardized set of measures used to evaluate how well health insurance plans deliver care and preventive services. Think of it like a report card that compares plans on things such as screenings, chronic-disease management and vaccination rates; investors monitor HEDIS scores because they affect plan reputation, consumer choice, quality-linked payments and regulatory scrutiny, all of which can influence membership, revenue and long-term growth.

transitions of care medical

"two HEDIS quality measures within Clover Health’s Medicare Advantage population: Transitions of Care"

The movement of a patient between different settings or levels of medical care—such as from hospital to home, from emergency room to inpatient ward, or from specialist to primary care—and the processes that ensure medical information, medications, and follow-up plans move with them. It matters to investors because smooth transitions reduce readmissions, errors, and costs while improving outcomes; companies that provide coordination tools, services, or technology can affect healthcare spending and provider performance in measurable ways.

follow-up after emergency department visit for people with multiple high-risk chronic conditions medical

"Follow-Up After Emergency Department Visit for People with Multiple High-Risk Chronic Conditions"

A health-care quality measure that tracks whether patients with several serious chronic illnesses see a doctor or care team soon after leaving an emergency department. It captures how well providers arrange post-discharge care for high-risk patients, similar to a follow-up phone call after a stressful event to prevent problems getting worse. Investors use it as a signal of clinical coordination, potential readmission rates, and downstream costs that can affect hospital, insurer, and managed-care performance.

medication reconciliation medical

"a 33% higher rate of receipt of discharge information and an 11% higher rate of medication reconciliation"

Medication reconciliation is the process health providers use to create and maintain an accurate, complete list of a patient’s medicines whenever care is transferred or a record is updated, comparing what a patient is actually taking with what is prescribed. It matters to investors because effective reconciliation reduces medical errors, regulatory risk, hospital readmissions and avoidable costs, and therefore can affect clinical outcomes, operational performance and reimbursement metrics.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CA-enabled PCPs showed better HEDIS® post-acute performance, including 33% higher discharge information receipt and an 11% higher rate of post-discharge medication reconciliation, underscoring the role of AI-enabled workflows in high-risk care transitions

SAN FRANCISCO, July 07, 2026 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or “Clover Health”), and a leading AI-powered physician enablement platform, today released findings within the whitepaper “Clinical Excellence in Continuity of Care: A Real-World Analysis of Counterpart Assistant's Role in Post-Hospitalization Follow-up.”

The whitepaper examines the relationship between CA use by primary care physicians (“PCPs”) and performance on high-risk care transition outcomes, including two HEDIS®¹ quality measures within Clover Health’s Medicare Advantage population: Transitions of Care (“TRC”) and Follow-Up After Emergency Department Visit for People with Multiple High-Risk Chronic Conditions (“FMC”).

Counterpart Health partners with payers and provider organizations to help primary care teams identify care gaps, manage risk, and improve quality and financial performance across populations with complex clinical needs. For transitions of care, CA helps turn acute utilization events into timely, trackable follow-up work by generating tasks after hospital discharge and surfacing available hospitalization information, including medication information, lab results, procedures, and discharge summaries, within clinicians’ existing workflows.

"Patients are at their most vulnerable when they are discharged from the hospital, where communication gaps and missed follow-ups with their PCP can lead to avoidable complications," said David Tsay, MD, PhD, Chief Medical Officer at Counterpart Health and co-author of the whitepaper. "CA is supporting PCPs in ensuring follow-up care happens, and that patients are getting the proactive and longitudinal care they need.”

Key highlights from the whitepaper include:

• Stronger transitions of care performance: Members attributed to CA-enabled PCPs performed better across all HEDIS Transitions of Care measures reviewed, including notification of inpatient admission, patient engagement after discharge, receipt of discharge information, and medication reconciliation.
• More frequent post-discharge coordination: Members attributed to CA-enabled PCPs had a 33% higher rate of receipt of discharge information and an 11% higher rate of medication reconciliation post-discharge.
• More timely ED follow-up for high-risk members: Members attributed to CA-enabled PCPs had a 9% higher rate on the HEDIS FMC measure, which evaluates follow-up after emergency department visits for people with multiple high-risk chronic conditions.
  
  

"Primary care providers are often best positioned to identify emerging risks and intervene before they escalate, but they need timely, actionable information to do so," said Conrad Wai, Chief Executive Officer of Counterpart Health. "This analysis highlights how Counterpart Assistant can help bridge the gap between hospital discharge and outpatient management. By equipping providers with insights that support timely follow-up and patient engagement, we believe CA can strengthen care coordination, reduce avoidable acute utilization, and contribute to lower total cost of care."

This whitepaper is Counterpart’s eighth retrospective data analysis measuring CA's clinical impact, building on the care model and data foundation that supported Clover's #1 HEDIS score nationwide for a PPO Medicare Advantage plan for the last two years². By embedding post-acute needs into the existing clinical workflow, CA helps enable more timely follow-up during one of the most vulnerable periods in a patient’s care journey.

Counterpart Assistant is commercially available to interested plans and risk-bearing provider organizations looking to advance this work. To learn more about Counterpart Health, visit: www.counterparthealth.com.

About Counterpart Health

Counterpart Health, a subsidiary of Clover Health Investments, Corp., or Clover Health, is a leading AI-powered physician enablement platform transforming care delivery. Born out of Clover Health as Clover Assistant, Counterpart Health’s flagship software platform, Counterpart Assistant, provides clinically intuitive insights that help clinicians better manage chronic conditions and deliver high-quality care. Counterpart Health extends this powerful data-driven technology platform beyond Clover Health’s Medicare Advantage plan. Counterpart Assistant is now commercially available, bringing its benefits to a wider audience to improve patient outcomes and reduce healthcare costs nationwide. Several published studies document the technology’s ability to support better outcomes in areas such as Diabetes, Chronic Kidney Disease, Congestive Heart Failure, and Chronic Obstructive Pulmonary Disease management, as well as Clinical Quality and Underserved Patient Populations.

About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and aim to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale.
Visit: www.cloverhealth.com

Investor Relations:
Ryan Schmidt
investors@cloverhealth.com

Press Inquiries:
press@cloverhealth.com

______________________

¹ HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).
² This analysis focuses on performance by non-SNP PPO plans with over 2,000 lives as of September 1, 2025 and 2024 on HEDIS measures applicable to non-SNPs that were used for CMS’s MY 2023 and MY 2024 Star ratings, applying the measure ranges used by CMS.

FAQ

What did Clover Health (CLOV) announce about Counterpart Assistant on July 7, 2026?

Clover Health announced new whitepaper findings on Counterpart Assistant’s association with stronger care transition performance. According to Counterpart Health, CA-enabled primary care physicians showed better HEDIS Transitions of Care and FMC results within Clover’s Medicare Advantage population, including higher discharge information, medication reconciliation, and ED follow-up rates.

How did Counterpart Assistant affect HEDIS Transitions of Care measures for Clover Health (CLOV)?

Counterpart Assistant use was associated with better performance across all reviewed HEDIS Transitions of Care measures. According to Counterpart Health, members attributed to CA-enabled PCPs performed better on inpatient admission notification, patient engagement after discharge, receipt of discharge information, and medication reconciliation after hospitalization.

What do the 33% and 11% improvements linked to Counterpart Assistant (CLOV) represent?

The 33% and 11% figures reflect higher post-discharge coordination rates for CA-enabled PCPs. According to Counterpart Health, members with CA-enabled PCPs had a 33% higher rate of discharge information receipt and an 11% higher rate of post-discharge medication reconciliation compared with non-CA-attributed members.

How did Counterpart Assistant impact HEDIS FMC follow-up for high-risk Clover Health (CLOV) members?

Counterpart Assistant use was associated with more timely emergency department follow-up for high-risk members. According to Counterpart Health, members attributed to CA-enabled PCPs had a 9% higher rate on the HEDIS FMC measure, which tracks follow-up after ED visits for people with multiple high-risk chronic conditions.

How does Counterpart Assistant support post-hospitalization follow-up for Clover Health (CLOV) members?

Counterpart Assistant embeds post-acute needs into existing clinical workflows to support timely follow-up. According to Counterpart Health, CA generates follow-up tasks after discharge and surfaces hospitalization data, such as medications, labs, procedures, and discharge summaries, helping primary care teams manage high-risk care transitions more consistently.

Is Counterpart Assistant available beyond Clover Health (CLOV) Medicare Advantage members?

Yes, Counterpart Assistant is commercially available to external organizations. According to Counterpart Health, plans and risk-bearing provider groups interested in improving care transitions, quality performance, and management of complex populations can adopt CA to integrate post-acute workflows and support more proactive primary care.

How do the new Counterpart Assistant findings relate to Clover Health’s (CLOV) HEDIS performance?

The findings build on Clover Health’s existing HEDIS performance foundation. According to Counterpart Health, this is the eighth retrospective CA analysis and builds on the model and data supporting Clover’s #1 HEDIS score nationwide for a PPO Medicare Advantage plan over the last two years.